DEF: Sanara MedTech Inc. Announces Details for 2025 Annual Meeting of Shareholders

Sanara MedTech Inc. will hold its 2025 Annual Meeting of Shareholders virtually on May 22, 2025, to elect directors and ratify the appointment of its independent accounting firm.

Summary

• Sanara MedTech Inc. will hold its Annual Meeting of Shareholders virtually on May 22, 2025, at 10:00 a.m. Central Time.
• Shareholders of record as of April 11, 2025, are entitled to vote.
• The meeting will address the election of eight directors and the ratification of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Shareholders can vote online, by telephone, or by mail before the meeting, or virtually during the meeting.
• The Board recommends voting for the election of all director nominees and for the ratification of the accounting firm appointment.

Sentiment

Score: 7

Explanation: The document is a routine corporate communication with a neutral to slightly positive tone, reflecting standard governance procedures.

Positives

• The virtual format of the Annual Meeting aims to provide expanded access, improved communication, and cost savings for shareholders and the Company.
• Shareholders have multiple options for voting, including online, telephone, and mail, providing flexibility and convenience.
• The Board is comprised of individuals with diverse backgrounds and extensive experience in healthcare, finance, and technology.
• The audit committee is composed of independent directors with financial expertise.

Risks

• Failure to obtain a proxy from a broker, bank, or nominee may result in shares not being eligible to be voted at the Annual Meeting.
• If a quorum is not present, the meeting may be adjourned.
• Broker non-votes may occur if shareholders do not provide voting instructions to their brokers, banks, or nominees.

Future Outlook

The document outlines the procedures and proposals for the upcoming Annual Meeting, focusing on governance and operational continuity through the election of directors and ratification of the accounting firm.

Management Comments

• Ronald T. Nixon, Executive Chairman and Chief Executive Officer, urges shareholders to submit their vote as soon as possible and thanks them for their support.
• Management will be available to respond to questions from shareholders submitted in advance of the Annual Meeting.

Industry Context

This announcement is a standard corporate procedure for publicly traded companies, ensuring shareholder participation in key decisions regarding the company's leadership and financial oversight.

Comparison to Industry Standards

• Holding a virtual annual meeting is becoming increasingly common among publicly traded companies to enhance accessibility and reduce costs.
• The director compensation structure, including retainer fees and equity awards, is generally in line with industry practices for companies of similar size and stage.
• The process for shareholder proposals and director nominations adheres to SEC regulations and standard corporate governance practices.

Management Changes

Stakeholder Impact

• Shareholders are directly impacted through their voting rights on key company decisions.
• Employees may be indirectly impacted by the election of directors and the ratification of the accounting firm, which can influence company strategy and financial stability.

Next Steps

• Shareholders should review the proxy materials and vote on the proposals.
• The Company will hold the Annual Meeting on May 22, 2025.
• The Company will publish the voting results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Shareholders, Directors, Proxy Statement, Sanara MedTech, Weaver and Tidwell, Voting, Corporate Governance